USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ADVANCED SENSOR TECHNOLOGIES, INC.
Address:
39255 Country Club Drive Suite B-12
Farmington Hills, MI 48331
Phone:
(248) 553-9375
URL:
N/A
EIN:
383343676
DUNS:
14443423
Number of Employees:
10
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,285,227.00 15
SBIR Phase II $3,532,332.00 5

Award List:

MULTISITE POTENTIO/AMPEROMETRIC NEURAL SENSOR ARRAY

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Cantor, Hal C
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$98,624.00
Agency / Branch:
DOD / DARPA
Principal Investigator:
Hal C. Cantor, President, Director R&D
Abstract:
N/a

Chip-Scale Integrated Micro-fluidic System, Including Valves and Pumps, for use in Transdermal Biological Monitoring

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$400,295.00
Agency / Branch:
DOD / DARPA
Principal Investigator:
Hal Cantor, President, Director R&D
Abstract:
Advanced Sensors Technologies, Inc. (AST) proposes to manufacture and test its DARPA funded Phase I SBIR designs of an integrated microfluidic sensor system with the goal of online, real-time monitoring of biological fluids. The MEMS microfluidic systemincorporates AST's innovative designs for… More

Chip-Scale Integrated Micro-fluidic System, Including Valves and Pumps, for use in Transdermal Biological Monitoring

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency / Branch:
DOD / DARPA
Principal Investigator:
Hal Cantor, President, Director R&D
Abstract:
Advanced Sensors Technologies, Inc. (AST) proposes to manufacture and test its DARPA funded Phase I SBIR designs of an integrated microfluidic sensor system with the goal of online, real-time monitoring of biological fluids. The MEMS microfluidic systemincorporates AST's innovative designs for… More

Real-Time Melatonin Monitor to Diagnose Sleep Disorders

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$99,556.00
Agency:
HHS
Principal Investigator:
Hal C. Cantor
Abstract:
With an ever-growing elderly population, it is becoming increasingly important to monitor physiological correlates associated with age. One major problem associated with age revolves around quantity and quality of sleep. Many commercial devices monitor physiometric nocturnal activity (i.e.… More

Integrated Three Dimensional Micro-Fluidics with Pumps, Valves, and Sensors

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$98,945.00
Agency / Branch:
DOD / DARPA
Principal Investigator:
Hal C. Cantor, President, Director R&D
Abstract:
"Significant obstacles to the widespread adoption of integrated micro-fluidic devices include their relatively low fluidic circuit density and high cost. To obviate these limitations, Advanced Sensor Technologies, Inc. (AST) proposes to develop thetechnologies to allow fabrication of… More

Lightweight Biosensor Badge to Monitor Environmental Organophosphates

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$69,914.00
Agency / Branch:
DOD / CBD
Principal Investigator:
Hal C. Cantor, Ph.D., President, Director R&D
Abstract:
"The US Joint Services, Federal Agencies, and state and local First Responders have expressed dissatisfaction with currently employed organophosphate (OP) sensors. They have identified the need for a new generation of sensors that is small, light-weight,and easy to use while being capable of… More

PERSONAL MONITOR TO DETECT EXPOSURE TO TOXIC AGENTS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,855.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (Applicant's abstract): Toward the goal of developing an automated, miniaturized device to detect the body's reaction to exposure to environmental toxins, Advanced Sensor Technologies, Inc. proposes to develop a miniature device capable of providing differential… More

Non-Invasive, Continuous, Transdermal Glucose Monitor w/Actuator Control

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,989.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Hal C. Cantor, President & CTO
Abstract:
"AST proposes to develop a non-invasive methodology able to continuously monitor blood glucose concentration. As opposed to employing near infrared spectroscopy, which suffers from the limitations of sensitivity, stability, and repeatability, AST intendsto employ direct measurement of glucose, via… More

Personal Monitor to Detect Exposure to Toxic Agents

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$756,065.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Advanced Sensor Technologies, Inc. (AST) proposes to continue its NIH funded Phase I efforts to develop a completely automated miniaturized device capable of monitoring different types of cholinesterases from a single drop of whole blood to determine the degree… More

Non-Invasive, Continuous, Transdermal Glucose Monitor w/Actuator Control

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$729,610.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Hal C. Cantor, Ph.D., President and CTO
Abstract:
AST is developing a non-invasive methodology to continuously monitor blood glucose concentration. As opposed to employing near infrared spectroscopy, which suffers from limitations of sensitivity, stability, and repeatability, AST employs directmeasurement of glucose, via amperometric sensors, from… More

SBIR Phase I: Closed Loop Drug Delivery System

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$99,993.00
Agency:
NSF
Principal Investigator:
Hal Cantor
Abstract:
This Small Business Innovation Research (SBIR) Phase I project is to develop a device to deliver therapeutic drugs in a controlled and monitored manner. This device will be used to control delivery of therapeutic doses of drugs, and to monitor blood levels of such drugs continuously, with on-demand… More

Real-Time Melatonin Monitor to Diagnose Sleep Disorder

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$916,895.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): With an ever-growing elderly population, it is becoming increasingly important to monitor physiological correlates associated with age. One major problem associated with age revolves around quantity and quality of sleep. Many commercial devices monitor… More

Study of Peripheral Immune Effects and Pathway on Brain

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$99,977.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): There exists a growing body of evidence, both experimental and clinical, which supports the concept of intimate communication between the central nervous and immune systems to maintain homeostasis and health. Data support the fact that this interrelationship is… More

Real-Time Melatonin Monitor to Diagnose Sleep Disorder

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): With an ever-growing elderly population, it is becoming increasingly important to monitor physiological correlates associated with age. One major problem associated with age revolves around quantity and quality of sleep. Many commercial devices monitor… More

SBIR TOPIC 192 - BIOREACTOR TO MONITOR CNCR MMP'S

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$99,964.00
Agency:
HHS
Principal Investigator:
Hal Cantor
Abstract:
N/a

Novel Routes of Drug Administration to Enhance Compliance in Soldiers

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$119,169.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Hal Cantor, President & CTO
Abstract:
WHO estimates that between 300 and 500 million new cases of malaria occur each year and annual deaths from the disease number between 2 and 3 million. Although there are several compounds known to be effective for treating malaria, including quinine, doxycycline, primaquine, azithromycin, and… More

Transdermal Patch for Pulsatile Nicotine Delivery

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Current nicotine delivery patches rely on the passive diffusion of nicotine through the skin and into the fluid that surrounds the cells beneath the skin (interstitial fluid). From there, the nicotine diffuses into the capillary network, enters the blood… More

Novel Routes of Drug Administration to Enhance Compliance in Soldiers

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$729,467.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Hal C. Cantor, President
Abstract:
WHO estimates that between 300 and 500 million new cases of malaria occur each year and annual deaths from the disease number between 2 and 3 million. Although there are several compounds known to be effective for treating malaria, including quinine, doxycycline, primaquine, azithromycin, and… More

Transdermal GnRH Delivery System to Treat Infertility

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$99,241.00
Agency:
HHS
Principal Investigator:
Kenneth H. Swartz
Abstract:
DESCRIPTION (provided by applicant): The ability to conceive and maintain a pregnancy is a desire most couples expect to fulfill in their lifetime. However, infertility affects between eight and fifteen percent of the American population. One of the most common causes of female infertility is… More